Extension of toxSYN Platform with Best-in-Class Linker-Payloads Based on Validated Topiosomerase 1 Inhibitor (Exatecan) & DNA-damaging Agent (Calicheamicin)

Time: 10:00 am
day: Day Two


  • SYNtecan E™ and SYNeamicin G™ linker-payloads show excellent in vivo efficacy and tolerability
  • Immunogenic cell-death driven by SYNtecan E™ ADCs corroborated in syngeneic mouse models
  • Comprehensive set of linker-payloads enables matching of payload MOA to any clinical indication